国际心肺移植学会共识会议共识声明:心力衰竭相关心源性休克
国际心肺移植学会组织54名来自42个中心的专家,围绕心力衰竭相关心源性休克(HF-CS)的定义、诊断与管理达成共识。共识涵盖CS管理系统(hub-and-spoke模式与分层网络)、转诊时最低数据要求、休克团队学科构成、机械循环支持装置选择目标及最佳流量等议题,旨在明确已达成的共识并促进未来研究与登记。
要点
- HF-CS患者中除及时心肌血运重建外,尚无治疗被证明可改善生存。
- 共识涵盖CS管理系统、转诊数据、休克团队、MCS装置选择与流量等议题。
- 该共识基于会前调查与分组讨论,在缺乏稳健数据的情况下达成。
核心结论
- 该文件就HF-CS管理中的若干重要问题提供了专家共识,期望明确已达成的共识领域并促进未来研究与登记以填补关键知识缺口。
研究设计与样本
- 国际心肺移植学会组织共识会议,54名参与者(晚期心衰与介入心脏病学家、心胸外科医生、重症心脏病学家、重症监护医师、药师及联合健康专业人员)代表全球42个中心,基于会前调查与分组讨论就预设临床议题达成共识。
主要发现
- 心源性休克死亡率接近50%,除及时心肌血运重建外无治疗被证明可改善生存。
- 多数研究集中于急性心肌梗死患者,指导HF-CS患者的证据很少。
- 共识讨论了CS管理系统(hub-and-spoke模式与分层网络)、转诊时最低数据要求、休克团队学科构成、MCS装置选择目标及最佳流量等议题。
局限性
- 共识在缺乏稳健数据的情况下达成。
- 原文希望该共识能激发未来研究与登记以提供关于其他关键知识缺口的见解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The last decade has brought tremendous interest in the problem of cardiogenic shock. However, the mortality rate of this syndrome approaches 50%, and other than prompt myocardial revascularization, there have been no treatments proven to improve the survival of these patients. The bulk of studies have been in patients with acute myocardial infarction, and there is little evidence to guide the clinician in those patients with heart failure cardiogenic shock (HF-CS). An International Society for Heart and Lung Transplant consensus conference was organized to better define, diagnose, and manage HF-CS. There were 54 participants (advanced heart failure and interventional cardiologists, cardiothoracic surgeons, critical care cardiologists, intensivists, pharmacists, and allied health professionals) with vast clinical and published experience in CS, representing 42 centers worldwide. This consensus report summarizes the results of a premeeting survey answered by participants and the breakout sessions where predefined clinical issues were discussed to achieve consensus in the absence of robust data. Key issues discussed include systems for CS management, including the "hub-and-spoke" model vs a tier-based network, minimum levels of data to communicate when considering transfer, disciplines that should be involved in a "shock team," goals for mechanical circulatory support device selection, and optimal flow on such devices. Overall, the document provides expert consensus on some important issues facing practitioners managing HF-CS. It is hoped that this will clarify areas where consensus has been reached and stimulate future research and registries to provide insight regarding other crucial knowledge gaps.
引用
- Baran DA, Billia F, Randhawa V, et al. Consensus statements from the International Society for Heart and Lung Transplantation consensus conference: Heart failure-related cardiogenic shock. J Heart Lung Transplant. 2023. PMID: 38069919. doi:10.1016/j.healun.2023.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。